MACULASER

maculaser-logo

TEMPERATURE CONTROLLED LASER THERAPY

#People #Financial #Website #More

MACULASER

Social Links:

Founded:
2020-01-01

Address:
Helsinki, Southern Finland, Finland

Country:
Finland

Website Url:
http://www.maculaser.com

Total Employee:
1+

Status:
Active

Total Funding:
1.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Current Employees Featured

jani-tirronen_image

Jani Tirronen
Jani Tirronen Co-Founder & Chief Executive Officer @ Maculaser
Co-Founder & Chief Executive Officer
2020-09-01

jaakko-nieminen_image

Jaakko Nieminen
Jaakko Nieminen CTO @ Maculaser
CTO
2022-02-01

ossi-kaikkonen_image

Ossi Kaikkonen
Ossi Kaikkonen Founder and Head of product @ Maculaser
Founder and Head of product
2022-02-01

teemu-turunen_image

Teemu Turunen
Teemu Turunen Co-Founder & Chief Scientific Officer @ Maculaser
Co-Founder & Chief Scientific Officer
2020-09-01

Founder


jani-tirronen_image

Jani Tirronen

ossi-kaikkonen_image

Ossi Kaikkonen

teemu-turunen_image

Teemu Turunen

Investors List

innovestor_image

Innovestor

Innovestor investment in Seed Round - Maculaser

Official Site Inspections

http://www.maculaser.com

  • Host name: fi-s1.seravo.net
  • IP address: 95.216.46.32
  • Location: Finland
  • Latitude: 60.1717
  • Longitude: 24.9349
  • Timezone: Europe/Helsinki

Loading ...

More informations about "Maculaser"

Maculaser โ€“ Pioneering retinal treatment

Maculaserโ€™s pioneering retinal treatment triggers the natural healing response of senescent cells with personalized heat exposure. Targeting disease prevention, we offer a patient-specific, โ€ฆSee details»

Company โ€“ Maculaser

Rooted in pioneering research in the top biomedical engineering laboratory at Aalto University, Finland, since 2013, Maculaser aims to revolutionize retinal healthcare. Targeting conditions โ€ฆSee details»

Maculaser - Crunchbase Company Profile & Funding

Maculaser is a clinical phase medical technology company. Maculaser develops novel medical technology for the treatment of common retinal diseases. They offer services that include age โ€ฆSee details»

Maculaser Ltd - LinkedIn

Restoring retinal health | Maculaser develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration.See details»

Science โ€“ Maculaser

Activation of autophagy is key to retinal health, engaging in the removal and recycling of cellular waste to rejuvenate the retina. Autophagy targets old, damaged cell components, enhancing โ€ฆSee details»

Maculaser Company Profile 2024: Valuation, Funding & Investors

Developer of novel laser therapy technology designed to prevent blindness by targeting major retinal diseases.See details»

Maculaser - Products, Competitors, Financials, Employees, โ€ฆ

Maculaser is a medical technology company focused on the development of novel laser therapy for retinal diseases. Use the CB Insights Platform to explore Maculaser's full profile.See details»

Maculaser | Aalto University

Maculaserโ€™s pioneering retinal treatment triggers the natural healing response of senescent cells with personalized heat exposure. Targeting disease prevention, we offer a patient-specific, โ€ฆSee details»

Innovestor invests in Maculaser - Developing new laser therapy ...

Feb 10, 2021ย ยท Finnish medtech startup, Maculaser, has raised a โ‚ฌ1.2 million funding round for their patented laser treatment technology that aims to halt the progression of blinding retinal โ€ฆSee details»

Maculaser raised โ‚ฌ1.2 million in funding to combat blindness

Finnish medtech startup, Health Incubator Helsinki company Maculaser has raised a โ‚ฌ1.2 million funding round for their patented laser treatment technology that aims to halt the progression of โ€ฆSee details»

Maculaser - Contacts, Employees, Board Members, Advisors

Maculaser has 4 current employee profiles, including Co-Founder & Chief Executive Officer Jani Tirronen. Maculaser is a clinical phase medical technology company.See details»

Maculaser - VentureRadar

Maculaser project develops novel medical technology for treatment of common retinal diseases, including dry Age-related Macular Degeneration. The core of our innovation is the precise โ€ฆSee details»

Close-up conversation with Jani Tirronen, CEO and co-founder of โ€ฆ

Jun 9, 2023ย ยท Jani is the CEO and co-founder of Maculaser, a med-tech startup from Finland, aiming to solve the most common cause of blindness; retinal diseases.See details»

Technology โ€“ Maculaser

Our solution employs retinal temperature monitoring designed to ensure safe, effective, and consistent treatments for every patient, taking into account inter-patient variability and โ€ฆSee details»

Maculaser combats blindness โ€“ Health Capital Helsinki

Oct 15, 2020ย ยท Maculaser is one of the companies determined to fight blindness. By targeting retinal diseases, this medical technology company aims to radically change how the common โ€ฆSee details»

Maculaser | Aalto University

Apr 10, 2018ย ยท The Maculaser heat treatment heats the back of the eye with a near-infrared laser while precisely controlling the temperature during the treatment. The goal is to treat age โ€ฆSee details»

Maculaser to raise a โ‚ฌ1.2 million funding round led by Innovestor.

Feb 9, 2021ย ยท Maculaser, a Helsinki, Finland-based developer of novel medical technology for treatment of common retinal diseases, announced closing funding of โ‚ฌ1.2 million ($1.5M). The โ€ฆSee details»

Articles โ€“ Maculaser

Jun 11, 2024ย ยท Maculaser, a company developing treatments for retinal disorders that affect millions of people worldwide and that currently have no effective. Maculaserโ€™s novel โ€ฆSee details»

Maculaser - EU-Startups

Maculaser ERG-based technology enables real-time and personalized control of temperature of the retina during non-damaging ophthalmic laser treatments.See details»

Pipeline โ€“ Maculaser

We are confidently progressing toward efficacy evaluations and commercial readiness. With diverse clinical studies planned, including wet and dry AMD as well as macular edemas, we โ€ฆSee details»

linkstock.net © 2022. All rights reserved